Global DNA Probe-based Diagnostic Market Research Report 2023

Publication ID:

PB504233223

Publication Date:

April 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global DNA Probe-based Diagnostic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for DNA Probe-based Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for DNA Probe-based Diagnostic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for DNA Probe-based Diagnostic in Cancer Testing is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of DNA Probe-based Diagnostic include Abbott Laboratories, BD, Thermo Fisher Scientific, F. Hoffmann La Roche, Luminex, bioMerieux, BioGenex US, MP Biomedicals and Biolegio, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Probe-based Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Probe-based Diagnostic.
The DNA Probe-based Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global DNA Probe-based Diagnostic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Probe-based Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
BD
Thermo Fisher Scientific
F. Hoffmann La Roche
Luminex
bioMerieux
BioGenex US
MP Biomedicals
Biolegio
GE Healthcare
Segment by Type
DNA Probes-Based Products
Direct Detection of Target Sequence
Nucleic Acid Amplification
Gene Detection Using DNA Chips
Gene Detection by DNA Sequencing
Segment by Application
Cancer Testing
Infectious Disease Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Probe-based Diagnostic companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Probe-based Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DNA Probes-Based Products
1.2.3 Direct Detection of Target Sequence
1.2.4 Nucleic Acid Amplification
1.2.5 Gene Detection Using DNA Chips
1.2.6 Gene Detection by DNA Sequencing
1.3 Market by Application
1.3.1 Global DNA Probe-based Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer Testing
1.3.3 Infectious Disease Testing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Probe-based Diagnostic Market Perspective (2018-2029)
2.2 DNA Probe-based Diagnostic Growth Trends by Region
2.2.1 Global DNA Probe-based Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 DNA Probe-based Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 DNA Probe-based Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 DNA Probe-based Diagnostic Market Dynamics
2.3.1 DNA Probe-based Diagnostic Industry Trends
2.3.2 DNA Probe-based Diagnostic Market Drivers
2.3.3 DNA Probe-based Diagnostic Market Challenges
2.3.4 DNA Probe-based Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Probe-based Diagnostic Players by Revenue
3.1.1 Global Top DNA Probe-based Diagnostic Players by Revenue (2018-2023)
3.1.2 Global DNA Probe-based Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global DNA Probe-based Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by DNA Probe-based Diagnostic Revenue
3.4 Global DNA Probe-based Diagnostic Market Concentration Ratio
3.4.1 Global DNA Probe-based Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Probe-based Diagnostic Revenue in 2022
3.5 DNA Probe-based Diagnostic Key Players Head office and Area Served
3.6 Key Players DNA Probe-based Diagnostic Product Solution and Service
3.7 Date of Enter into DNA Probe-based Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Probe-based Diagnostic Breakdown Data by Type
4.1 Global DNA Probe-based Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global DNA Probe-based Diagnostic Forecasted Market Size by Type (2024-2029)
5 DNA Probe-based Diagnostic Breakdown Data by Application
5.1 Global DNA Probe-based Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global DNA Probe-based Diagnostic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America DNA Probe-based Diagnostic Market Size (2018-2029)
6.2 North America DNA Probe-based Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America DNA Probe-based Diagnostic Market Size by Country (2018-2023)
6.4 North America DNA Probe-based Diagnostic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Probe-based Diagnostic Market Size (2018-2029)
7.2 Europe DNA Probe-based Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe DNA Probe-based Diagnostic Market Size by Country (2018-2023)
7.4 Europe DNA Probe-based Diagnostic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Probe-based Diagnostic Market Size (2018-2029)
8.2 Asia-Pacific DNA Probe-based Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific DNA Probe-based Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific DNA Probe-based Diagnostic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Probe-based Diagnostic Market Size (2018-2029)
9.2 Latin America DNA Probe-based Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America DNA Probe-based Diagnostic Market Size by Country (2018-2023)
9.4 Latin America DNA Probe-based Diagnostic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Probe-based Diagnostic Market Size (2018-2029)
10.2 Middle East & Africa DNA Probe-based Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa DNA Probe-based Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa DNA Probe-based Diagnostic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories DNA Probe-based Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD DNA Probe-based Diagnostic Introduction
11.2.4 BD Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.2.5 BD Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific DNA Probe-based Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 F. Hoffmann La Roche
11.4.1 F. Hoffmann La Roche Company Detail
11.4.2 F. Hoffmann La Roche Business Overview
11.4.3 F. Hoffmann La Roche DNA Probe-based Diagnostic Introduction
11.4.4 F. Hoffmann La Roche Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.4.5 F. Hoffmann La Roche Recent Development
11.5 Luminex
11.5.1 Luminex Company Detail
11.5.2 Luminex Business Overview
11.5.3 Luminex DNA Probe-based Diagnostic Introduction
11.5.4 Luminex Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.5.5 Luminex Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux DNA Probe-based Diagnostic Introduction
11.6.4 bioMerieux Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.6.5 bioMerieux Recent Development
11.7 BioGenex US
11.7.1 BioGenex US Company Detail
11.7.2 BioGenex US Business Overview
11.7.3 BioGenex US DNA Probe-based Diagnostic Introduction
11.7.4 BioGenex US Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.7.5 BioGenex US Recent Development
11.8 MP Biomedicals
11.8.1 MP Biomedicals Company Detail
11.8.2 MP Biomedicals Business Overview
11.8.3 MP Biomedicals DNA Probe-based Diagnostic Introduction
11.8.4 MP Biomedicals Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.8.5 MP Biomedicals Recent Development
11.9 Biolegio
11.9.1 Biolegio Company Detail
11.9.2 Biolegio Business Overview
11.9.3 Biolegio DNA Probe-based Diagnostic Introduction
11.9.4 Biolegio Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.9.5 Biolegio Recent Development
11.10 GE Healthcare
11.10.1 GE Healthcare Company Detail
11.10.2 GE Healthcare Business Overview
11.10.3 GE Healthcare DNA Probe-based Diagnostic Introduction
11.10.4 GE Healthcare Revenue in DNA Probe-based Diagnostic Business (2018-2023)
11.10.5 GE Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
BD
Thermo Fisher Scientific
F. Hoffmann La Roche
Luminex
bioMerieux
BioGenex US
MP Biomedicals
Biolegio
GE Healthcare

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂